Description
The therapeutic antibody field has matured to the point where antibody based drugs have become commonly prescribed for many indication, particularly in cancer and rheumatology. This conference will bring together basic scientists, clinicians, and pharmaceutical industry scientists engaged in antibody drug discovery and development to provide a view of the current state of the art and areas for future progress.
